Guido Dalbagni, MD

About Me

I am a urologic surgeon with expertise in the treatment of urologic tumors — which include bladder, urethral, and kidney cancers. I am currently heading clinical trials at Memorial Sloan Kettering to evaluate new therapies for the treatment of high-risk superficial bladder cancer in patients who are resistant to bacillus Calmette-Guérin (BCG) therapy, the standard treatment. I also have expertise in nerve-sparing radical cystectomy followed by bladder reconstruction. I have written a number of articles, and I am on the editorial boards of and a reviewer for several peer-reviewed journals.

Read more
  • Clinical Expertise: Bladder Cancer; Upper Tract; Urologic Oncology; Kidney Cancer
  • Languages Spoken: English
  • Education: MD, Cairo University Faculty of Medicine (Egypt); MD, University of Parma (Italy)
  • Residencies: Cabrini Medical Center (New York); New York University Medical Center
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Urology

Appointments Available

Making an appointment

Call 646-497-9068

See My Colleagues

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more